Jean-Manasse Theagene - Mar 31, 2024 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Jean-Manasse Theagene
Stock symbol
MAIA
Transactions as of
Mar 31, 2024
Transactions value $
$0
Form type
4
Date filed
4/2/2024, 04:52 PM
Previous filing
Jan 3, 2024
Next filing
Jul 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +9.19K $0.00 9.19K Mar 31, 2024 Common Stock 9.19K $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on March 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.